Asked if psychogenetic profiling could alleviate the “rollercoaster” effect frequently associated with current medication regimes, Sean points out one of the universal truths hindering treatment using prescribed drugs – you gotta go the distance…
A brain scanner is a very serious piece of scientific kit with a massive price ticket beyond that of mere mortals – but, as the holidays approach, the SYNERGIES rTMS gang are hoping for something special in their stockings…
In a world where everyone starts off as “the norm”, when it comes to prescribing drugs, and then experiences the inevitable “suck it and see” effect, pharmacogenetics can identify more readily and accurately which direction to go in when looking for a more “effective” regime.
In an effort to clarify the mechanism behind rTMS and how much it relies on brain plasticity, Alynka identifies a dastardly dichotomy – how do you build the good connections without bringing the bad along with you…
Genetic “profiling” to optimise medication choice (Pharmacogenomics) has historically been priced out of the mainstream. Sean explains why this SYNERGIES programme could radically alter that situation…
In the previous episode we heard about the “mechanics” of receiving rTMS treatment but how, exactly, does flooding the brain with a magnetic field change the way we think?
Curieux de découvrir des recherches qui étudient le cerveau ? Curieux d’entendre les réflexions et questions de personnes concernées par des troubles
In this opening episode, after a spin through the funding landscape, PI Sean reveals the groundbreaking impetus behind the GLAD project – PLEX POWERED RESEARCH…
Curieux de découvrir des recherches qui étudient le cerveau ? Curieux d’entendre les réflexions et questions de personnes concernées par des troubles
Having already established that the PLEX – Research Partners won’t be the ones having their brains “zapped”, who exactly will be included in the upcoming clinical trial and how do they qualify?
